# Annovis Bio, Inc.: filings

ANVS · NYSE · CIK 1477845 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/anvs.md) · [Financials](/companies/anvs/financials.md) · [Filings](/companies/anvs/filings.md) · [Insiders](/companies/anvs/insiders.md)

## Reports and events: 126 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 83, 4 72, 10-Q 20, 424B5 15, CORRESP 10, 3 9, DEFA14A 9, UPLOAD 9, 4/A 8, D 8, DEF 14A 8, 10-K 7, S-1/A 6, 424B4 3, ARS 3, EFFECT 3, SC 13G 3, SC 13G/A 3, SCHEDULE 13G 3, 8-A12B 2, CERT 2, D/A 2, DRSLTR 2, FWP 2, PRE 14A 2, S-3 2, S-8 2, SCHEDULE 13G/A 2, 144 1, 25 1, 5 1, DRS 1, DRS/A 1, S-1 1, S-1MEF 1, S-3/A 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 17:10 ET | [8-K](/filings/0001104659-26-120732.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-120732 |
| 2026-10-20 | 19:49 ET | [8-K](/filings/0001104659-26-116995.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-116995 |
| 2026-09-11 | 16:53 ET | [DEF 14A](/filings/0001104659-26-107113.md) | Proxy statement, period 2026-10-14 | 0001104659-26-107113 |
| 2026-08-14 | 16:31 ET | [10-Q](/filings/0001104659-26-097228.md) | Quarterly report, period 2026-06-30 | 0001104659-26-097228 |
| 2026-08-14 | 16:05 ET | [8-K](/filings/0001104659-26-097091.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-097091 |
| 2026-07-10 | 21:06 ET | [8-K](/filings/0001104659-26-082341.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-082341 |
| 2026-06-17 | 16:50 ET | [8-K](/filings/0001104659-26-075198.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-26-075198 |
| 2026-05-20 | 16:15 ET | [8-K](/filings/0001104659-26-064514.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-064514 |
| 2026-05-15 | 16:30 ET | [10-Q](/filings/0001104659-26-062626.md) | Quarterly report, period 2026-03-31 | 0001104659-26-062626 |
| 2026-05-15 | 16:00 ET | [8-K](/filings/0001104659-26-062451.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-062451 |
| 2026-04-30 | 16:55 ET | [DEF 14A](/filings/0001104659-26-053096.md) | Proxy statement, period 2026-06-17 | 0001104659-26-053096 |
| 2026-04-10 | 17:50 ET | [8-K](/filings/0001104659-26-041584.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-041584 |
| 2026-03-25 | 17:19 ET | [8-K](/filings/0001104659-26-034611.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-034611 |
| 2026-03-16 | 17:06 ET | [8-K](/filings/0001104659-26-028574.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-028574 |
| 2026-03-13 | 17:15 ET | [10-K](/filings/0001104659-26-027751.md) | Annual report, period 2025-12-31 | 0001104659-26-027751 |
| 2026-02-12 | 09:00 ET | [8-K](/filings/0001104659-26-013948.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-013948 |
| 2026-01-28 | 16:28 ET | [8-K](/filings/0001104659-26-007423.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-007423 |
| 2025-11-13 | 17:49 ET | [8-K](/filings/0001104659-25-110548.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-110548 |
| 2025-11-12 | 16:16 ET | [10-Q](/filings/0001104659-25-110393.md) | Quarterly report, period 2025-09-30 | 0001104659-25-110393 |
| 2025-10-28 | 17:07 ET | [8-K](/filings/0001104659-25-103254.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-103254 |
| 2025-10-14 | 17:19 ET | [8-K](/filings/0001104659-25-099356.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-099356 |
| 2025-09-29 | 16:31 ET | [8-K](/filings/0001104659-25-094522.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-094522 |
| 2025-08-15 | 16:15 ET | [8-K](/filings/0001104659-25-079248.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-079248 |
| 2025-08-12 | 16:31 ET | [10-Q](/filings/0001558370-25-011233.md) | Quarterly report, period 2025-06-30 | 0001558370-25-011233 |
| 2025-08-12 | 16:16 ET | [8-K](/filings/0001104659-25-076851.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-076851 |
| 2025-06-23 | 17:25 ET | [8-K](/filings/0001104659-25-061751.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-25-061751 |
| 2025-06-20 | 06:01 ET | [8-K](/filings/0001104659-25-060784.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-060784 |
| 2025-05-13 | 16:41 ET | [8-K](/filings/0001104659-25-047871.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-25-047871 |
| 2025-05-13 | 16:36 ET | [10-Q](/filings/0001558370-25-007584.md) | Quarterly report, period 2025-03-31 | 0001558370-25-007584 |
| 2025-04-30 | 17:20 ET | [DEF 14A](/filings/0001104659-25-042679.md) | Proxy statement, period 2025-06-17 | 0001104659-25-042679 |
| 2025-03-27 | 16:35 ET | [8-K](/filings/0001104659-25-028803.md) | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-028803 |
| 2025-03-21 | 17:15 ET | [10-K](/filings/0001558370-25-003482.md) | Annual report, period 2024-12-31 | 0001558370-25-003482 |
| 2025-03-21 | 17:10 ET | [8-K](/filings/0001104659-25-026714.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-25-026714 |
| 2025-02-05 | 08:08 ET | [8-K](/filings/0001104659-25-009387.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-009387 |
| 2025-02-05 | 21:18 ET | [8-K](/filings/0001104659-25-009279.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-009279 |
| 2024-12-11 | 16:25 ET | [8-K](/filings/0001104659-24-127626.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-127626 |
| 2024-12-11 | 06:10 ET | [8-K](/filings/0001104659-24-127439.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-24-127439 |
| 2024-12-09 | 16:15 ET | [8-K](/filings/0001104659-24-126761.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-126761 |
| 2024-11-12 | 06:02 ET | [8-K](/filings/0001104659-24-116086.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-116086 |
| 2024-11-08 | 17:08 ET | [10-Q](/filings/0001558370-24-015074.md) | Quarterly report, period 2024-09-30 | 0001558370-24-015074 |
| 2024-10-15 | 08:12 ET | [8-K](/filings/0001104659-24-108360.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-108360 |
| 2024-09-30 | 08:38 ET | [8-K](/filings/0001104659-24-104002.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-104002 |
| 2024-08-15 | 07:15 ET | [8-K](/filings/0001104659-24-089913.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-24-089913 |
| 2024-08-14 | 16:05 ET | [10-Q](/filings/0001558370-24-012227.md) | Quarterly report, period 2024-06-30 | 0001558370-24-012227 |
| 2024-08-06 | 08:09 ET | [8-K](/filings/0001104659-24-086114.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-086114 |
| 2024-07-16 | 08:05 ET | [8-K](/filings/0001104659-24-080039.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-080039 |
| 2024-07-10 | 16:05 ET | [8-K](/filings/0001104659-24-078937.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-078937 |
| 2024-07-02 | 08:14 ET | [8-K](/filings/0001104659-24-077093.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-077093 |
| 2024-06-13 | 06:05 ET | [8-K](/filings/0001104659-24-071011.md) | 5.07 Shareholder vote results | 0001104659-24-071011 |
| 2024-06-11 | 17:00 ET | [8-K](/filings/0001104659-24-070450.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-070450 |

Page 1 of 3. [Older](/companies/anvs/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 17:19 ET. No prices; not investment advice.